Literature DB >> 3282230

An 11-kDa form of human immunodeficiency virus protease expressed in Escherichia coli is sufficient for enzymatic activity.

M C Graves1, J J Lim, E P Heimer, R A Kramer.   

Abstract

In order to define the protease domain of human immunodeficiency virus 1, various regions of the pol open reading frame were cloned and expressed in Escherichia coli. Antiserum directed against the conserved retroviral protease active site was used to identify pol precursor and processed species containing the presumed protease domain. The smallest product that accumulates is about 11 kDa as measured by NaDodSO4/PAGE. This size agrees with that predicted from the presence in this region of two Phe-Pro sequences, which is one of the cleavage sites recognized by HIV protease. DNA encoding only the predicted 11-kDa protein was cloned, bypassing the need for autoprocessing, and the protein was expressed to a high level in E. coli. This form is active as demonstrated by its ability to specifically cleave protease-deficient pol protein in vivo in E. coli. Extracts of E. coli containing the 11-kDa protease also process human immunodeficiency virus gag substrates in vitro. These results demonstrate that the 11-kDa protease is sufficient for enzymatic activity and are consistent with a major role for this form in virus maturation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3282230      PMCID: PMC280014          DOI: 10.1073/pnas.85.8.2449

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  5 in total

1.  The binding of haemoglobin by plasma proteins (haptoglobins); its bearing on the renal threshold for haemoglobin and the aetiology of haemoglobinuria.

Authors:  A C ALLISON; W A REES
Journal:  Br Med J       Date:  1957-11-16

2.  Zone electrophoresis in starch gels: group variations in the serum proteins of normal human adults.

Authors:  O SMITHIES
Journal:  Biochem J       Date:  1955-12       Impact factor: 3.857

3.  Studies on the serum haptoglobin level in hemoglobinemia and its influence on renal excretion of hemoglobin.

Authors:  C B LAURELL; M NYMAN
Journal:  Blood       Date:  1957-06       Impact factor: 22.113

4.  Clinical determination of the sites of red cell sequestration in hemolytic anemias.

Authors:  J H JANDL; M S GREENBERG; R H YONEMOTO; W B CASTLE
Journal:  J Clin Invest       Date:  1956-08       Impact factor: 14.808

5.  Notation for serum-protein groups and the genes controlling their inheritance.

Authors:  O SMITHIES; N F WALKER
Journal:  Nature       Date:  1956-09-29       Impact factor: 49.962

  5 in total
  35 in total

1.  Thermodynamic linkage between the binding of protons and inhibitors to HIV-1 protease.

Authors:  J Trylska; J Antosiewicz; M Geller; C N Hodge; R M Klabe; M S Head; M K Gilson
Journal:  Protein Sci       Date:  1999-01       Impact factor: 6.725

Review 2.  Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS.

Authors:  Arun K Ghosh; Heather L Osswald; Gary Prato
Journal:  J Med Chem       Date:  2016-01-22       Impact factor: 7.446

3.  Mutational analysis of human immunodeficiency virus type 1 protease suggests functional homology with aspartic proteinases.

Authors:  D D Loeb; C A Hutchison; M H Edgell; W G Farmerie; R Swanstrom
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles.

Authors:  A J Smith; M I Cho; M L Hammarskjöld; D Rekosh
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

5.  Deletion of sequences upstream of the proteinase improves the proteolytic processing of human immunodeficiency virus type 1.

Authors:  K Partin; G Zybarth; L Ehrlich; M DeCrombrugghe; E Wimmer; C Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

6.  Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein.

Authors:  R J Tritch; Y E Cheng; F H Yin; S Erickson-Viitanen
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

Review 7.  High molecular mass intracellular proteases.

Authors:  A J Rivett
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

8.  Isolation of mutants of human immunodeficiency virus protease based on the toxicity of the enzyme in Escherichia coli.

Authors:  E Z Baum; G A Bebernitz; Y Gluzman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

9.  Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria.

Authors:  J Luban; C Lee; S P Goff
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Structure of HIV-1 protease in complex with potent inhibitor KNI-272 determined by high-resolution X-ray and neutron crystallography.

Authors:  Motoyasu Adachi; Takashi Ohhara; Kazuo Kurihara; Taro Tamada; Eijiro Honjo; Nobuo Okazaki; Shigeki Arai; Yoshinari Shoyama; Kaname Kimura; Hiroyoshi Matsumura; Shigeru Sugiyama; Hiroaki Adachi; Kazufumi Takano; Yusuke Mori; Koushi Hidaka; Tooru Kimura; Yoshio Hayashi; Yoshiaki Kiso; Ryota Kuroki
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.